Clinical Trial Update: Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors [Phase 4]

View source ↗

Summary

This study evaluates whether surgical debulking prior to peptide receptor radionuclide therapy improves outcomes in well-differentiated gastroenteropancreatic n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2 | Phase 4 | Status: RECRUITING